Product
CVI-HBV-002
3 clinical trials
3 indications
Indication
Vaccine-Preventable DiseasesIndication
Hepatitis BIndication
ChronicClinical trial
A Randomized, Open-labelled, Parallel, Phase 1 Clinical Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Hepatitis B Vaccine CVI-HBV-002 in AdultsStatus: Completed, Estimated PCD: 2023-09-25
Clinical trial
A Randomized, Double-blinded, Placebo-controlled, Parallel, Multicenter, Phase 2b Study to Evaluate the Efficacy and Safety of CVI-HBV-002 in Patients With Chronic Hepatitis B Taking TenofovirStatus: Completed, Estimated PCD: 2023-12-04
Clinical trial
A Single Center, Open Labeled Phase I/IIa Study to Evaluate Safety, Tolerability and Efficacy of a Therapeutic Hepatitis B Vaccine in Oral Antiviral Drug-treated Chronic Hepatitis B Virus CarriersStatus: Completed, Estimated PCD: 2017-08-22